They may have referred to the red highlighted portion when they said "Vantrela may not prevent oral abuse".
I am rather concerned about anther section at the end.
"About 20,000 Americans died from overdosing on prescription opioid painkillers in 2014, more than triple the number in 2001, according to the National Institutes of Health. Deaths from heroin, which also is an opioid, rose to 12,000 from 2,000 in the same period."
This seems to be biggest issue right now. In order to solve this issue, we need a new technology.
Maybe I don't know the definition of the FDA version of "Abuse Deterrent" well. It is correct to understand that the FDA is ok even if a product can be overdosed as long as it prevents other forms of abuse right now? May be that is FDA's current position.
The FDA is pressured but they are also pragmatic. I am hoping SequestOX is getting the abuse deterrent label before the next generation of ADT/ART. It is better that other products in this sector at this moment. IMO